Clinical Trial Update: Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of irinotecan for previously treated, advanced non-small cell lung cancer was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-04-13